Coronavirus Drugs

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

China has requisitioned medical supplies production across the country as millions struggle to obtain basic drugs and testing kits in the face of a surge in Covid-19 cases.

Cities in China began distributing free anti-fever drugs to the public, as COVID-19 sweeps through the world's most populous country largely unchecked for the first time after an abrupt shift in the country's containment policies.

Tired of being cooped up to comply with China's strict anti-COVID rules, people awaited clarity on an easing of restrictions that could be announced as soon as Wednesday, while the more cautious rushed to buy cold medicines and home test kits.

Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.

The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada

An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.

The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.

Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.

Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.

Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.

China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.

A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

China has requisitioned medical supplies production across the country as millions struggle to obtain basic drugs and testing kits in the face of a surge in Covid-19 cases.

Cities in China began distributing free anti-fever drugs to the public, as COVID-19 sweeps through the world's most populous country largely unchecked for the first time after an abrupt shift in the country's containment policies.

Tired of being cooped up to comply with China's strict anti-COVID rules, people awaited clarity on an easing of restrictions that could be announced as soon as Wednesday, while the more cautious rushed to buy cold medicines and home test kits.

Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.

The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada

An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.

The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.

Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.

Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.

Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.

China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.

A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.